Tong Lu

1.7k total citations
67 papers, 1.1k citations indexed

About

Tong Lu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Tong Lu has authored 67 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 21 papers in Pulmonary and Respiratory Medicine and 19 papers in Cancer Research. Recurrent topics in Tong Lu's work include RNA modifications and cancer (16 papers), Cancer-related molecular mechanisms research (14 papers) and Circular RNAs in diseases (12 papers). Tong Lu is often cited by papers focused on RNA modifications and cancer (16 papers), Cancer-related molecular mechanisms research (14 papers) and Circular RNAs in diseases (12 papers). Tong Lu collaborates with scholars based in China, United States and India. Tong Lu's co-authors include Yuanyong Wang, Wenjie Jiao, Xiao Sun, Shicheng Li, Shuncheng Miao, Yang Wo, Jia Liu, Di Chen, Ran Xu and Jiaying Zhao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and ACS Applied Materials & Interfaces.

In The Last Decade

Tong Lu

63 papers receiving 1.0k citations

Peers

Tong Lu
Tong Lu
Citations per year, relative to Tong Lu Tong Lu (= 1×) peers Qingcheng Yang

Countries citing papers authored by Tong Lu

Since Specialization
Citations

This map shows the geographic impact of Tong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tong Lu more than expected).

Fields of papers citing papers by Tong Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tong Lu. The network helps show where Tong Lu may publish in the future.

Co-authorship network of co-authors of Tong Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Tong Lu. A scholar is included among the top collaborators of Tong Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tong Lu. Tong Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Tong, Fanchao Wei, Xinglin He, et al.. (2025). The role of inflammation and ROS in CaOx kidney stones. European journal of medical research. 30(1). 1224–1224.
2.
Gu, Qiang, Kan Wang, Tong Lu, et al.. (2025). Single-cell and spatial transcriptome analyses reveal MAZ(+) NPC-like clusters as key role contributing to glioma recurrence and drug resistance. Journal of Translational Medicine. 23(1). 657–657. 4 indexed citations
3.
Yang, Ping, et al.. (2024). The impact of gut microbiota in full‐term pregnant women on immune regulation during pregnancy: A prospective, exploratory study. Journal of obstetrics and gynaecology research. 51(1). e16180–e16180. 2 indexed citations
5.
Zhou, Chenfei, Jinling Jiang, Xiaojun Xiang, et al.. (2024). Preclinical investigations and a first-in-human phase 1a trial of JS007, a novel anti-CTLA-4 antibody, in patients with advanced solid tumors. Experimental Hematology and Oncology. 13(1). 98–98. 1 indexed citations
6.
Xue, Yi, Sheng Huang, Tong Lu, et al.. (2024). Development and validation of an automated Tomotherapy planning method for cervical cancer. Radiation Oncology. 19(1). 88–88. 3 indexed citations
7.
Yang, Ping, Guangyu Ma, Tong Lu, et al.. (2024). The influence of the oral microbiota in full-term pregnant women on immune regulation during pregnancy. Journal of Reproductive Immunology. 165. 104298–104298. 2 indexed citations
8.
Zhou, Xiang, Rongjian Xu, Tong Lu, et al.. (2023). Identification of immunotherapy biomarkers for improving the clinical outcome of homologous recombination deficiency patients with lung adenocarcinoma. Aging. 15(16). 8090–8112. 1 indexed citations
9.
Shi, Jiaxin, Bo Peng, Xiang Zhou, et al.. (2023). An anoikis-based gene signature for predicting prognosis in malignant pleural mesothelioma and revealing immune infiltration. Journal of Cancer Research and Clinical Oncology. 149(13). 12089–12102. 2 indexed citations
10.
Wang, Chenghao, Tong Lu, Ran Xu, et al.. (2022). A bioinformatics-based immune-related prognostic index for lung adenocarcinoma that predicts patient response to immunotherapy and common treatments. Journal of Thoracic Disease. 14(6). 2131–2146. 3 indexed citations
11.
Wang, Jun, Huawei Li, Ran Xu, et al.. (2022). The MLR, NLR, PLR and D-dimer are associated with clinical outcome in lung cancer patients treated with surgery. BMC Pulmonary Medicine. 22(1). 104–104. 36 indexed citations
12.
Wang, Yuanyong, Yang Wo, Tong Lu, et al.. (2021). Circ-AASDH functions as the progression of early stage lung adenocarcinoma by targeting miR-140-3p to activate E2F7 expression. Translational Lung Cancer Research. 10(1). 57–70. 26 indexed citations
13.
Sun, Xiao, Yunpeng Xuan, Yandong Zhao, et al.. (2020). Relevance and prognostic ability of Twist, Slug and tumor spread through air spaces in lung adenocarcinoma. Cancer Medicine. 9(6). 1986–1998. 16 indexed citations
14.
Lu, Tong, Tong Qiu, Bin Han, et al.. (2020). Circular RNA circCSNK1G3 induces HOXA10 signaling and promotes the growth and metastasis of lung adenocarcinoma cells through hsa-miR-143-3p sponging. Cellular Oncology. 44(2). 297–310. 23 indexed citations
15.
Wang, Yuanyong, Rongjian Xu, Dongyang Zhang, et al.. (2019). Circ-ZKSCAN1 regulates FAM83A expression and inactivates MAPK signaling by targeting miR-330-5p to promote non-small cell lung cancer progression. Translational Lung Cancer Research. 8(6). 862–875. 76 indexed citations
16.
Chen, Di, Tong Lu, Kun Zhao, et al.. (2019). <p>Identification of a transcription factor-microRNA network in esophageal adenocarcinoma through bioinformatics analysis and validation through qRT-PCR</p>. Cancer Management and Research. Volume 11. 3315–3326. 4 indexed citations
17.
Lu, Tong, Quan Huang, Junjiang Fu, et al.. (2019). Proteasome-dependent degradation of Smad7 is critical for lung cancer metastasis. Cell Death and Differentiation. 27(6). 1795–1806. 40 indexed citations
18.
Lu, Tong, Yuanyong Wang, Di Chen, Jia Liu, & Wenjie Jiao. (2018). Potential clinical application of lncRNAs in non-small cell lung cancer. OncoTargets and Therapy. Volume 11. 8045–8052. 76 indexed citations
19.
Li, Shicheng, Ronghua Yang, Xiao Sun, et al.. (2018). Identification of SPP1 as a promising biomarker to predict clinical outcome of lung adenocarcinoma individuals. Gene. 679. 398–404. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026